Showing 2031-2040 of 2235 results for "".
- Alastin Skincare Products Now Available in Canadahttps://modernaesthetics.com/news/alastin-skincare-products-now-available-in-canada/2473003/Alastin Skincare, Inc. is now available in Caanada via partnership with AVARI Medical Ltd. "Alastin Skincare has established a leadership position in the US, achieving the fastest growth rate in the professional skincare channel for three years in a row. In addition to contin
- Allergan Buys Luminera Dermal-Filler Businesshttps://modernaesthetics.com/news/allergan-buys-luminera-dermal-filler-business/2473000/Allergan Aesthetics, an AbbVie company, has acquired Luminera's full dermal filler portfolio and R&D pipeline. Luminera is a privately held aesthetics company based in Israel with a portfolio and pipeline of dermal filler products. "
- Cynosure Taps Vet Dr. Rafael Sierra for R&D Positionhttps://modernaesthetics.com/news/cynosure-taps-vet-rafael-sierra-phd-for-rd-position/2472992/Rafael Sierra, PhD is back at Cynosure. The former Chief Technology Officer is now an R&D Advisor. "Dr. Sierra's passion for the science behind medical aesthetics and inherent knowledge of its clinical application are unparalleled," says Todd
- NYC Dermatologist Dr. Doris Day Joins Nufabrx’s Ad Boardhttps://modernaesthetics.com/news/nyc-dermatologist-dr-doris-day-joins-nufabrxs-ad-board/2472988/New York City dermatologist Doris Day, MD is the newest member of Nufabrx’s advisory board. Nufabrx is an advanced textiles company that has developed a proprietary biomaterial platform that embeds active ingredient
- Amore Pacific Gets Woke with Enough Project Lifestyle Brandhttps://modernaesthetics.com/news/amore-pacific-gets-woke-with-enough-project-lifestyle-brand/2472983/South Korea’s Amorepacific is launching its newest vegan-friendly lifestyle brand: Enough Project. This new brand is vegan-friendly, involves no animal testing, and contains no animal ingredients. In a
- Estée Lauder and Atropos Therapeutics Team Up to Discover Senomodulatorshttps://modernaesthetics.com/news/estee-lauder-and-atropos-therapeutics-team-up-to-discover-senomodulators/2472980/The Estée Lauder Companies and Atropos Therapeutics are joining forces to discover botanical senomodulators or senescence-modulating chemicals. Atropos Therapeutics Inc. has a proprietary platform to identify a
- Here’s What’s Been Happening at Merz Aestheticshttps://modernaesthetics.com/news/heres-whats-been-happening-at-merz-aesthetics/2472979/Merz Aesthetics is launching its new “confidence to be” branding platform following the conclusion of the company’s reorganization. Merz is now three independently operating businesses: medical aesthetics, therapeutics and consumer care. “The new brand
- BTL Files New Complaint Against Allergan, Affiliates in Patent Fighthttps://modernaesthetics.com/news/btl-files-new-complaint-against-allergan-affiliates-in-patent-fight/2472976/BTL Industries, Inc. has filed a complaint with the United States International Trade Commission (ITC), asking the Commission to prevent Allergan Limited, Allergan, Inc., Allergan USA Inc., Zeltiq Aesthetics, Inc., Zeltiq Ireland Unlimited Company, and Zimmer MedizinSysteme GmbH, G
- SoftWave Tissue Regeneration Technologies Announces Plan for Cellulite Trialhttps://modernaesthetics.com/news/softwave-tissue-regeneration-technologies-announces-plan-for-cellulite-trial/2472974/SoftWave Tissue Regeneration Technologies plans to start a 60-patient study to evaluate the safety and efficacy of the DermaGold device for the temporary improvement in the appearance of cellulite. The company has a patent for the use
- NYC Plastic Surgeon Dr. Sachin Shridharani Joins Soliton’s Scientific Advisory Boardhttps://modernaesthetics.com/news/sachin-shridharani-md-joins-solitons-scientific-advisory-board/2472973/Sachin Shridharani, MD has joined Soliton, Inc’s Scientific Advisory Board. Soliton, Inc. recently filed for 510(k) premarket clearance with the U.S. Food and Drug Administration (FDA) of its second-generation Rapid Acoustic Pulse (RAP) device for the reduction in the appearance o